Potent FP Receptor Bimatoprost (AGN 192024) Cas Number 155206-00-1

Basic Info

Model No.: 155206-00-1

Additional Info

Packaging: As required

Productivity: Commercial

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Certificate: Technical Support

Product Description

Bimatoprost cas number 155206-00-1 is a second-generation pro- glaucoma-resistant glaucoma drug that has become a first-line anti-glaucoma preparation in most parts of the world. Unlike latanoprost and travoprost, it is a synthetic prostaglandin that selectively mimics the action of naturally occurring prostaglandins with a dual depressurization mechanism that can increase aqueous humor through the trabecular meshwork and Two outflow pathways of grape sclera reduce intraocular pressure. Clinical studies have shown that drop of Bimatoprost cas 155206-00-1 every night can reduce intraocular pressure by 7 to 8 mmHg. After about the first 4 hours of instillation, the intraocular pressure began to decrease, and the effect was maximized within about 8 to 12 hours. It has been reported in the literature that the average intraocular pressure-lowering effect of Bimatoprost can reach more than 30%. Compared with timolol, the ocular hypotensive effect of the two has significant differences. Compared with latanoprost, Bimatoprost reduces intraocular pressure in patients with glaucoma, normal glaucoma, or ocular hypertension; the latest study shows that for intraocular pressure control of exfoliative glaucoma, Bimatoprost also has a better effect than latanoprost. Compared with travoprost, Bimatoprost also provides better intraocular pressure reduction, and more patients can achieve lower target intraocular pressure by using Bimatoprost cas number 155206-00-1.

Thera. Category:  Anti-glaucoma

Cas No.:155206-00-1 

Synonyms: LUMIGAN; Bimatoprost(TM); 17-phenyl TRINOR prostaglandin F2ALPHA ethyl amide; Bimatoprost(LUMIGAN);

NW: 415.5656

M.W.:C25H37NO4

Assay: ≥99%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request